Learning objectives:

After watching this webinar, participants will know:

• how to use cardiac imaging in the diagnosis and management of patients with carcinoid syndrome and AL amyloidosis; and
• the new recommendations of the 2022 ESC Guidelines on Cardio-Oncology for these specific patient populations.

Needs assessment:

• To highlight the crucial role of cardiac imaging in the diagnosis and management of carcinoid syndrome and AL amyloidosis, as outlined in the new 2022 ESC Guidelines on Cardio-Oncology. 

See "more details" for subsequent webinar topics.

Main topic 

• Imaging

Related topic

• Cardio-Oncology

For more information about the "2022 ESC Guidelines Series on Cardio-Oncology", please check the following webinars:

• What we need to know before cancer therapy 08/09/22
• Who needs cardiovascular surveillance after cancer treatment? 12/09/22
• How to manage cancer therapy-related cardiovascular toxicity 19/09/22
• How to organise cardiovascular monitoring during cancer treatment: who, when and how 26/09/22
• The role of cardiac imaging in the new 2022 ESC Guidelines on Cardio-Oncology 16/11/2022

Session information

This webinar is designed for cardiologists working in the field of cardiovascular imaging, and those wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.